EPISODE · Jun 23, 2026 · 1H 3M
Translating Science into Patient Impact with Kendra Rose
from Nucleate Podcast · host Nucleate
Time Stamps: (2:37) Introduction to Kendra’s professional journey and how she found her path into science (7:30) Understanding the consumer mindset and patient perspectives (13:05) Key parameters that shape important decisions (17:45) Core lessons on bridging the gap between science and business (25:30) Introduction to Bayer and Kendra’s role as Senior Vice President of Business Development and Licensing (29:46) Latest trends shaping healthcare research, education, and innovation (38:59) How to establish credibility as an entrepreneur in a competitive market (41:28) Inside the Bayer Co.Lab incubator ecosystem and the support it offers (50:37) Tips for early-career scientists interested in making a pivot from the lab to business (57:09) Do you really need a Ph.D. to break into pharma? (1:00:01) Quick fire questions
Embed this episode
What this episode covers
In this episode we are joined by Kendra Rose, Senior Vice President of BD&L at Bayer, who brings a blend of scientific depth and business acumen to the conversation. Her journey began with a passion for science which led her to pursue a Ph.D. in chemistry at Stanford University, before making a pivot to take her expertise into industry and joining Johnson & Johnson, then Novartis, and now Bayer. Kendra reflects on the lessons that have shaped her career and offers advice for early-stage founders and scientists considering a similar path. The conversation covers everything from understanding consumer needs to the latest trends driving healthcare innovation. She also offers a look into the Bayer Co.Lab incubator ecosystem, sharing insights on what it takes to succeed in a competitive market.
Ready to play
Translating Science into Patient Impact with Kendra Rose
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.